VEGF/FGF antagonists(3DP)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameVEGF/FGF antagonists(3DP)
Drug Alias NameFGF antagonists(3DP)fibroblast growth factor antagonists(3DP)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonistsFibroblast growth factor 2 inhibitors
TargetsFibroblast growth factor 2Vascular endothelial growth factor receptor
Therapy Area/IndicationsSolid tumoursAngiogenesis disorderWounds and Injuries +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator Companies3-Dimensional Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies3-Dimensional Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursAngiogenesis disorderWounds and Injuries +[4] 

Other Information

ATC CodeN/A
Related LinksN/A